| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 66.7% | 14/21 |
| Female | 33.3% | 7/21 |
| Indifferent | 0% | 0/21 |
| Unknown | 0% | 0/21 |
| General | ||
| 4.8% | 1/21 | |
| 4.8% | 1/21 | |
| 19% | 4/21 | |
| 19% | 4/21 | |
| 14.3% | 3/21 | |
| 71.4% | 15/21 | |
| 66.7% | 14/21 | |
| 90.5% | 19/21 | |
| 71.4% | 15/21 | |
| 66.7% | 10/15 | |
| Neurology | ||
| 66.7% | 14/21 | |
| 61.9% | 13/21 | |
| 61.9% | 13/21 | |
| Facial abnormalities | ||
| 42.9% | 9/21 | |
| 52.4% | 11/21 | |
| 57.1% | 12/21 | |
| 61.9% | 13/21 | |
| Visual and hearing impairments | ||
| 4.8% | 1/21 | |
| 4.8% | 1/21 | |
| Heart | ||
| 23.8% | 5/21 | |
| Pulmonary | ||
| Abnormality of the lungs | 0% | 0/21 |
| Gastrointestinal | ||
| 9.5% | 2/21 | |
| Urogenital | ||
| 23.8% | 5/21 | |
| Skeleton | ||
| 47.6% | 10/21 | |
| Skin / Hair / Nails | ||
| 33.3% | 7/21 | |
| Endocrine / Immunological / Metabolic | ||
| Endocrine | 0% | 0/21 |
| Metabolic | 0% | 0/21 |
| 4.8% | 1/21 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/21 |
| Inheritance | ||
| 47.6% | 10/21 | |
NFIB